A Shot of Hope: South Africa’s Historic Approval of Twice-Yearly HIV Injection Marks a New Dawn
In a monumental stride towards ending the HIV epidemic, South Africa has boldly stepped into a new era of prevention by approving Lenacapavir, a revolutionary long-acting injectable that provides robust protection against the virus with just two shots a year. This landmark decision by the South African Health Products Regulatory Authority (SAHPRA) positions the nation—which…








